订阅小程序
旧版功能

Impact of the Treatment Crossover Design on Comparative Efficacy in EMPOWER-Lung 1: Cemiplimab Monotherapy As First-Line Treatment of Advanced Non-Small Cell Lung Cancer

Josephine Louella Feliciano,Dylan McLoone,Yingxin Xu,Ruben G. W. Quek,Andreas Kuznik,Jean-Francois Pouliot,Giuseppe Gullo,Petra Rietschel,Patricia Guyot,Gerasimos Konidaris, Keith Chan,Sam Keeping,Florence R. Wilson,Nick Freemantle

FRONTIERS IN ONCOLOGY（2023）

引用 3|浏览19
关键词
non-small cell lung cancer,first-line treatment,cemiplimab,crossover design,EMPOWER-lung 1,chemotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要